Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efalizumab in Hand and Foot Plaque Psoriasis
NCT00312026Phase 4Completed
- Sponsor
- Genentech
- Start
- Mar 2006
- Primary completion
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 4 trial of efalizumab in plaque psoriasis, sponsored by Genentech. Started Mar 2006; status: completed.
02
Drugs
efalizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00312026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312026.